Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 12 → 13·22:13, 26 Oct 2024
Difference between revision 12 and revision 13 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 12 — 22:37, 14 Oct 2024 MassSpecMarv (talk) add the monitoring recommendation as attributed to the labelling 3,137 bytes ±0 | Revision 13 — 22:13, 26 Oct 2024 ToneTilda (talk) add the medical-disclaimer cross-link 3,137 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |